Efficacy of Dapagliflozin by Baseline Diabetes Medications: A Perspecified Analysis From the DAPA-CKD Study

Authors: Beernink, J. M., Persson, F., Jongs, N., Laverman, G. D., Chertow, G. M., McMurray, J. J. V., Langkilde, A. M., Correa-Rotter, R., Rossing, P., Sjöström, C. D.

Source: Diabetes care. 46(3):602-607

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN632843379&indx=1&recIds=ETOCRN632843379

Effects of Dapagliflozin on Hospitalizations in Patients With Chronic Kidney Disease. A Post Hoc Analysis of DAPA-CKD

Authors: Schechter, M., Jongs, N., Chertow, G. M., Mosenzon, O., McMurray, J. J. V., Correa-Rotter, R., Rossing, P., Langkilde, A. M., Sjöström, C. D., Toto, R. D.

Source: Annals of internal medicine. 176(1):59-66

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN630952565&indx=1&recIds=ETOCRN630952565

Patients with a range of rheumatic diseases are at increased risk of cardiovascular disorders towards a re-evaluation of the European League against Rheumatism (EULAR)'s recommendations for cardiovascular risk management?

Authors: Conrad, N., McInnes, I. B., Mcmurray, J. J. V., Sattar, N.

Source: Annals of the rheumatic diseases. 82(4):457-459

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN631618102&indx=1&recIds=ETOCRN631618102

Protein Biomarkers and Cardiovascular Outcomes in People With Type 2 Diabetes and Acute Coronary Syndrome: The ELIXA Biomarker Study

Authors: Gerstein, H. C., Hess, S., Claggett, B., Dickstein, K., Kober, L., Maggioni, A. P., McMurray, J. J. V., Probstfield, J. L., Riddle, M. C., Tardif, J.-C.

Source: Diabetes care. 45(9):2152-2155

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN630153967&indx=1&recIds=ETOCRN630153967

Efficacy and Safety of Dapagliflozin by Baseline Glycemic Status: A Prespecified Analysis From the DAPA-CKD Trial

Authors: Persson, F., Rossing, Peter, Vart, P., Chertow, G. M., Hou, F. F., Jongs, N., McMurray, J. J. V., Correa-Rotter, R., Bajaj, H. S., Stefansson, B. V.

Source: Diabetes care. 44(8):1894-1897

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN627291058&indx=1&recIds=ETOCRN627291058

Increased Risk of Incident Heart Failure and Death Is Associated With Insulin Resistance in People With Newly Diagnosed Type 2 Diabetes: UKPDS 89

Authors: Wamil, M., Coleman, R. L., Adler, A. I., McMurray, J. J. V., Holman, R. R.

Source: Diabetes care. 44(8):1877-1884

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN627291035&indx=1&recIds=ETOCRN627291035

Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.

Authors: Solomon, S. D.¹ ssolomon@bwh.harvard.edu, McMurray, J. J. V.² john.mcmurray@glasgow.ac.uk, Vaduganathan, M.¹, Claggett, B.¹, Jhund, P. S.², Desai, A. S.¹, Henderson, A. D.², Lam, C. S. P.³, Pitt, B.⁴, Senni, M.⁵, Shah, S. J.⁶, Voors, A. A.⁷, Zannad, F.⁸, Abidin, I. Z.⁹, Alcocer-Gamba, M. A.¹⁰, Atherton, J. J.¹¹, Bauersachs, J.¹², Chang-Sheng, M.¹³, Chiang, C.-E.¹⁴, Chioncel, O.¹⁵

Source: New England Journal of Medicine. 10/24/2024, Vol. 391 Issue 16, p1475-1485. 11p.

Subject Terms: *VENTRICULAR ejection fraction, *HEART failure, *HEART failure patients, *MINERALOCORTICOID receptors, CARDIOVASCULAR disease related mortality

Dalcetrapib Reduces Risk of New-Onset Diabetes in Patients With Coronary Heart Disease

Authors: Schwartz, G. G., Leiter, L. A., Ballantyne, C. M., Barter, P. J., Black, D. M., Kallend, D., Laghrissi-Thode, F., Leitersdorf, E., McMurray, J. J. V., Nicholls, S. J.

Source: Diabetes care. 43(5):1077-1084

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN623943973&indx=1&recIds=ETOCRN623943973

Transcatheter Repair of Secondary Mitral Regurgitation

Authors: McMurray, J. J. V., Metra, M.

Source: New England journal of medicine. 388(22):2097-2098

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN632311412&indx=1&recIds=ETOCRN632311412

Lack of Benefit of Renin-Angiotensin System Inhibitors in COVID-19

Authors: Lee, M. M. Y., McMurray, J. J. V.

Source: JAMA. 329(14):1155-1156

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN631701692&indx=1&recIds=ETOCRN631701692

'Real World' Eligibility for Sacubitril/Valsartan in Unselected Heart Failure Patients: Data from the Swedish Heart Failure Registry

Authors: Simpson, Joanne, Benson, L., Jhund, P. S., Dahlström, U., McMurray, J. J. V., Lund, L. H.

Source: Cardiovascular drugs and therapy. 33(3):315-322

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100127259887.0x000001&indx=1&recIds=ETOCvdc_100127259887.0x000001

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

Authors: McMurray, J. J. V.

Source: New England journal of medicine. 381(21):1995-2008

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN622142981&indx=1&recIds=ETOCRN622142981

Risk of Incident Heart Failure in Patients With Diabetes and Asymptomatic Left Ventricular Systolic Dysfunction

Authors: Rørth, R., Jhund, P. S., Mogensen, U. M., Kristensen, S. L., Petrie, M. C., Køber, L., McMurray, J. J. V.

Source: Diabetes care. 41(6):1285-1291

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN616057650&indx=1&recIds=ETOCRN616057650

The effects of dapagliflozin on kidney and cardiovascular outcomes in patients with chronic kidney disease with and without heart failure

Authors: Heerspink, J L, Wheeler, D C, Vart, P, Jongs, N, Hou, F F, Langkilde, A M, Correa-Rotter, R, Rossing, P, Sjostrom, C D, Toto, R D, Chertow, G M, Stefansson, B V, McMurray, J J V

Source: European heart journal. 42(1)

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100132779438.0x000001&indx=1&recIds=ETOCvdc_100132779438.0x000001

Lung ultrasound in acute heart failure: association between quality of life, symptoms and B-lines

Authors: Lee, M, Campbell, R T, Claggett, B L, Lewis, E F, Groarke, J D, Docherty, K F, Lindner, M, Liu, J, Solomon, S D, McMurray, J J V, Platz, E

Source: European heart journal. 42(1)

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100132749774.0x000001&indx=1&recIds=ETOCvdc_100132749774.0x000001

Treatment of heart failure
Advanced medicine conference; Updates on major clinical advances

Authors: McMurray, J. J. V.

Source: HORIZONS IN MEDICINE. :129-143

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCCN058472280&indx=1&recIds=ETOCCN058472280

Chronic kidney disease in patients with cardiac disease: A review of evidence-based treatment
Cardiovasacular and renal progression factors in chronic kidney disease: a colloquium in honor of John H. Dirks : ISN world congress of nephrology

Authors: McMurray, J. J. V.

Source: KIDNEY INTERNATIONAL. 68(NO 4):1419-1426

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCCN057502287&indx=1&recIds=ETOCCN057502287

Treatments that improve outcome in the patient with heart failure, left ventricular systolic dysfunction, or both after acute myocardial infarction
From CCU to CHF: bridging the treatment gap

Authors: Weir, R., McMurray, J. J. V.

Source: HEART -LONDON- BMJ PUBLISHING GROUP-. 91(SUPP/2):ii17-ii20

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCCN055173847&indx=1&recIds=ETOCCN055173847

Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure

Authors: McMurray, J. J. V.

Source: New England journal of medicine. 374(16):1521-1532

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN609954794&indx=1&recIds=ETOCRN609954794

Clinical Trials Series: Lessons in Uncertainty and Humility — Clinical Trials Involving Hypertension

Authors: Pfeffer, M. A., McMurray, J. J. V.

Source: New England journal of medicine. 375(18):1756-1766

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN608492402&indx=1&recIds=ETOCRN608492402